Allergy Therapeutics Market Cap

Allergy Therapeutics has a market cap or net worth of 417.95 million as of July 7, 2026. Its market cap has increased by 13.88% in one year.

Market Cap

417.95M

Enterprise Value

434.61M

Revenue

57.29M

Ranking

n/a

PE Ratio

n/a

Stock Price

6.60

Market Cap Chart

Since October 11, 2004, Allergy Therapeutics's market cap has increased from 30.57M to 417.95M, an increase of 1,267.20%. That is a compound annual growth rate of 12.78%.

Market Cap History

Date	Market Cap	% Change
Jul 7, 2026	417.95M	-38.13%
Dec 31, 2025	675.56M	118.05%
Dec 31, 2024	309.82M	160.00%
Dec 29, 2023	119.16M	180.75%
Dec 30, 2022	42.44M	-79.49%
Dec 31, 2021	206.98M	94.57%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Haleon	32.12B
Hikma Pharmaceuticals	3.29B
HUTCHMED (China)	1.53B
Venture Life Group	81.02M
Shield Therapeutics	65.71M
ECO Animal Health Group	64.71M
Provexis	29.56M
Hellenic Dynamics	1.32M

Market Cap Rankings